Saga Communications announced that Chief Executive Officer Christopher Forgy began a temporary medical leave of absence effective Friday, with the company’s executive team stepping in to manage operations during an indefinite recovery period.
Nutriband Inc. has officially terminated its agreement to sell subsidiary Pocono Pharmaceuticals to Earth Vision Bio, citing a failure by the buyer to meet financial obligations. The decision follows a series of missed late fees after the transaction failed to close by its original end-of-2025 deadline.
Ocular Therapeutix shares surged 15% in after-hours trading following the company’s announcement that it will release topline results from its Phase 3 clinical trial for Axpaxli this Tuesday. The study evaluates the treatment's efficacy for wet age-related macular degeneration (wet AMD), with the market anticipating key superiority data against current standards of care.
Disc Medicine shares plummeted 29% after the U.S. Food and Drug Administration denied accelerated approval for bitopertin, a potential therapy for the rare metabolic disorder erythropoietic protoporphyria.
Industrial technology specialist Enpro announced a 3.2% increase in its quarterly cash dividend on Friday, raising the payout to 32 cents per share. The board's decision brings the annualized distribution to $1.28, signaling a steady approach to shareholder returns and capital allocation.
Werewolf Therapeutics is undergoing a sweeping restructuring, cutting nearly two-thirds of its workforce and announcing the immediate departures of its finance and medical chiefs. The clinical-stage biopharmaceutical company expects to record a multi-million dollar charge as it drastically reduces its headcount to preserve capital.
PJM Interconnection has approved a 220-mile electricity transmission line proposed by NextEra Energy and Exelon, a project designed to stabilize the power grid across West Virginia and Pennsylvania. The initiative comes as regional energy infrastructure faces mounting pressure from rising demand that is currently outpacing supply.
Badger Meter’s board of directors has authorized a $75 million increase to its share repurchase program, effectively doubling the total capacity to $150 million through November 2028. The move underscores the water technology company's aggressive strategy to return capital to shareholders amid consistent financial performance.
CEA Industries has dismissed allegations from shareholder YZi Labs regarding potential Nasdaq listing violations, asserting that the company remains in full compliance despite delays in scheduling its annual meeting.
Harley-Davidson has raised its quarterly cash dividend by 4.2%, bringing the payout to $0.1875 per share and offering investors a 3.7% annual yield based on recent market valuations.
Energy shares climbed as intensifying geopolitical risks in the Middle East converged with a surge in infrastructure investment driven by the North American data center boom.
Clinical-stage biotechnology firm Longeveron has named industry veteran Stephen Willard as its new chief executive officer, effective Feb. 11. Willard, 65, takes the helm from interim leader Than Powell as the company seeks to stabilize its executive leadership and advance its clinical pipeline.
Cathay General Bancorp announced a 12% increase to its quarterly cash dividend on Friday, raising the payout to 38 cents per share. The boost signals a strengthened capital return strategy for the financial holding company as it prepares for a March distribution to stockholders.
Enbridge CEO Gregory Ebel has signaled the company will not pursue Alberta's proposed crude oil pipeline to the British Columbia coast, citing prohibitive political and policy risks. Speaking during a Friday earnings call, Ebel emphasized that the infrastructure giant is prioritizing stable investments over projects in jurisdictions with a history of regulatory uncertainty.
Shares of raw material producers climbed as gold futures surged 2% to $5,022 an ounce, marking a resilient recovery for precious metals. The rally comes as market analysts weigh the potential impact of the Trump administration’s proposed mineral stockpiling program on global supply chains and long-term inflation.
Antero Resources Corporation has reached a settlement with the U.S. Department of Justice and West Virginia regulators to resolve alleged Clean Air Act violations across its regional energy operations. The agreement, announced Friday, requires the company to pay millions in penalties and commit to extensive infrastructure upgrades to curb emissions.
Artivion shares tumbled Friday after the cardiac and vascular surgery specialist reported fourth-quarter adjusted earnings and revenue that fell just short of analyst expectations, overshadowing the company’s successful swing to a net profit.
Electrovaya shares tumbled Friday afternoon after the Canadian lithium-ion battery manufacturer reported fiscal first-quarter revenue that trailed Wall Street estimates, overshadowing a surprise jump in profitability. Despite the top-line miss, the company maintained an optimistic full-year outlook based on expanding market demand.
Graco board member Brett Carter has resigned from his position effective Thursday, the industrial manufacturer disclosed in a regulatory filing. The departure, which the company confirmed was not the result of any internal disputes, marks an immediate exit for a director whose term was slated to run through 2027.
Bright Horizons Family Solutions shares plummeted on Friday, hitting a one-year low after the child care provider reported fourth-quarter earnings that significantly trailed analyst expectations. Despite a modest beat on revenue, the company’s net income fell to $21.7 million, sparking a 21% sell-off that extended a year-long decline for the stock.
Flowers Foods shares plummeted 11% on Friday after the packaged bakery giant issued a disappointing 2026 forecast and announced a comprehensive strategic review to combat persistent industry headwinds. Despite beating fourth-quarter earnings estimates, the maker of Dave’s Killer Bread warned that a shorter fiscal year and shifting consumer habits would likely stifle growth in the coming year.
Constellation Brands shares fell 4.5% on Friday after the beverage giant announced that Nicholas Fink, the current head of Fortune Brands Innovations, will succeed Bill Newlands as chief executive officer on April 13.
Chemed Corp. announced Friday that its board of directors has approved an additional $300 million for its share repurchase program, signaling a commitment to returning capital to investors. The company, which maintains a diverse portfolio ranging from hospice care to plumbing services, will integrate the new capacity into its existing repurchase framework.
Shares of biosensor developer Profusa plummeted on Friday as the company moved to raise capital through a 5.1 million unit equity offering, erasing gains from a high-profile clinical partnership announced just one day prior.
HA Sustainable Infrastructure Capital shares climbed 10% after the climate-focused investment firm reported fourth-quarter revenue that surpassed Wall Street estimates, extending its year-to-date rally to 26%.
10x Genomics shares jumped 11% on Friday morning after the biotechnology firm reported a narrower-than-expected fourth-quarter loss and revenue that cleared Wall Street estimates. The company’s ability to curb losses and maintain international growth momentum offset a slight decline in its American operations, fueling investor confidence.
NextEra Energy has increased its quarterly dividend by 10%, raising the payout to 62.32 cents per share as the clean-energy giant continues to signal financial strength. The Juno Beach, Florida-based company announced the hike following a period of robust market performance, with the new payout schedule set to begin in mid-March.
Norwegian Cruise Line Holdings (NCLH) shares tumbled more than 6% on Friday following the appointment of former Subway chief John Chidsey as its next CEO. The leadership transition comes as the company faces a dual challenge of a J.P. Morgan downgrade and a strategic pivot toward the premium family market, raising concerns over near-term execution risks.
Petroleum futures retreated late Friday morning as Nymex contracts headed for a weekly decline, driven by stagnant U.S. gasoline demand and reports that OPEC+ may soon increase global production.
Ultragenyx Pharmaceutical shares tumbled Friday after the biotech firm announced a sweeping reorganization, including a 10% workforce reduction, in a bid to reach profitability by 2027. The move follows a quarterly earnings report that showed revenue growth overshadowed by a wider-than-expected loss.
